Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.


home / news releases / GMAB - Genmab's Tisotumab Vedotin In Metastatic Cervical Cancer

GMAB - Genmab's Tisotumab Vedotin In Metastatic Cervical Cancer

Genmab A/S
  • Genmab is collaborating with Seagen to launch tisotumab vedotin in hard to treat cervical cancer.
  • The market potential is below $1bn, but as the first commercial launch of an R&D behemoth, this is a substantial development.
  • In trials, the ADC has shown a better profile than Keytruda.

For further details see:

Genmab's Tisotumab Vedotin In Metastatic Cervical Cancer
Stock Information
Company Name: Genmab A/S
Stock Symbol: GMAB
Market: NASDAQ
Website: genmab.com
Menu
GMAB GMAB Quote GMAB Short GMAB News GMAB Articles GMAB Message Board
Get GMAB Alerts

News, Short Squeeze, Breakout and More Instantly...